Jiangxi Tianxu Pharmaceutical Co., Ltd. News
The supplied news document contains no details. It displays a page-not-found error.
Jiangxi Tianxu Pharmaceutical Co., Ltd.
江西天戌药业有限公司
Ticker
—
Listed market
—
Country
Employees (non-consolidated)
—
Related companies
0
§01
Basic information
- Head office
- Fenghou Industrial Park, Yihuang County, Fuzhou City, Jiangxi Province, China
- Chief executive
- Employees (non-consolidated)
- Employees (consolidated)
- Start date
- 2012-11-01
- End date
§02
Websites
§03
Business
Research and DevelopmentProductionSalesBulk DrugsPharmaceutical IntermediatesPesticide Intermediates
§04
Related companies
—
§05
Network
Drag to move · click to open
§06
History
Jiangxi Tianxu Pharmaceutical Co., Ltd. was established in November 2012 with a registered capital of 100 million yuan.
In 2018, Jiangxi Tianxu Pharmaceutical Co., Ltd. was rated as a "National High-Tech Enterprise" and a "Provincial Enterprise Technology Center".
In 2019, the company obtained the national "Drug Production License".
In June 2020, the company invested 150 million yuan to build a 2000-square-meter new product R&D center in Suzhou headquarters, adding more than 80 senior researchers with master's degrees or above. The new product research center is dedicated to developing high-level pharmaceutical intermediates and bulk drugs in cooperation with international pharmaceutical giants.
§07
News
Jiangxi Tianxu Pharmaceutical Co., Ltd. News
Dichloropyridine Acid Efficiently Controls Cirsium Arvense in Wheat Fields
Jiangxi Tianxu Pharmaceutical Co., Ltd. announced that its product dichloropyridine acid can effectively control Cirsium arvense in wheat fields. This new application helps improve crop protection in wheat fields. The news was released on August 10, 2019.
Canadian Federal Government Implements Pharmaceutical Pricing Reform Measures
This news was announced on August 10, 2019, and reports that the Canadian Federal Government has introduced reform measures regarding drug pricing. Details and impacts are not specified.
63 Organizations Formed a Biopharmaceutical Innovation Service Alliance in Chongqing
On August 10, 2019, Chongqing established a biopharmaceutical innovation service alliance composed of 63 organizations. The alliance aims to explore a trillion-yuan market and promote industry development and innovative cooperation.
Paradox in the Pharmaceutical Field: More Scientific Investment, Less Commercial Return?
The article explores the phenomenon in the pharmaceutical industry where increased investment in scientific research does not necessarily lead to proportional growth in commercial returns. This phenomenon prompts reflection on the efficiency of R&D investments and emphasizes the importance of optimizing resource allocation.
Research from Shanghai Jiao Tong University Shows Only a Small Portion of Our Population Has a Healthy Heart
Research from Shanghai Jiao Tong University indicates that only a minority of people in our country have a healthy heart. The study emphasizes the importance of heart health and urges the public to pay attention to the prevention and management of cardiovascular diseases.
Staying Up All Night and Using Air Conditioning Leads to Facial Paralysis! Remember These Things Before Using Air Conditioning for a Long Time
This article warns about health risks associated with prolonged use of air conditioning. In particular, it highlights that extended use of cooling can increase the risk of facial nerve paralysis (facial palsy), and introduces points to be cautious about before use.
Scientists Discover Multiple New Tumor Targets That Can Starve Tumors and Extend Mouse Survival
Scientists have identified multiple new tumor targets that can starve tumor cells and extend mouse survival. This discovery offers new potential targets and strategies for cancer treatment.
U.S. Revision of Dichlorophenylacetic Acid Residue Limits
On July 23, 2018, Jiangxi Tianxu Pharmaceutical Co., Ltd. reported the U.S. revision of the residue limits for dichlorophenylacetic acid. This revision may affect the usage standards of related drug intermediates. The specific details were not elaborated.
§09
Sources & updates
DOMAINOwn domain：Yes
UPDATED2026-09-30 02:21 · Model: ggml-org/gpt-oss-20b